An Open-Label Extension Trial of the Long-Term Safety of Nintedanib in Patients with Progessive Fibrosing Interstitial Lung Disease (PF-ILD)

  • Chaaban, Said (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/10/193/18/20